Colgate-Palmolive Company (LON:0P59)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 52.35B |
| Revenue (ttm) | 15.44B |
| Net Income (ttm) | 2.24B |
| Shares Out | n/a |
| EPS (ttm) | 2.73 |
| PE Ratio | 23.35 |
| Forward PE | 23.26 |
| Dividend | 1.57 (1.81%) |
| Ex-Dividend Date | Jul 18, 2025 |
| Volume | 733 |
| Average Volume | 2,156 |
| Open | 87.24 |
| Previous Close | 86.46 |
| Day's Range | 86.43 - 87.34 |
| 52-Week Range | 85.28 - 109.22 |
| Beta | 0.39 |
| RSI | 34.25 |
| Earnings Date | Aug 1, 2025 |
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells i... [Read more]
Financial Performance
In 2024, Colgate-Palmolive Company's revenue was $20.10 billion, an increase of 3.31% compared to the previous year's $19.46 billion. Earnings were $2.89 billion, an increase of 25.61%.
Financial numbers in USD Financial StatementsNews
Colgate-Palmolive: Brushing Off Big Returns
Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL stock is a Sell.
Dividend Roundup: CVS Health, Procter & Gamble, AbbVie, Colgate-Palmolive, and more
Colgate-Palmolive: Refreshingly Unexciting
Best Dividend Aristocrats For July 2025
Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising pa...
My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys
Markets remained volatile in May 2025 amid ongoing trade tensions and mixed signals from Washington and Wall Street. While U.S.-China talks quietly resumed, tariffs persisted and business sentiment st...
Colgate share: UBS maintains buy with Rs 3,000 target, sees attractive risk-reward despite near-term softness
UBS has reiterated a buy rating on Colgate-Palmolive India, setting a target price of ₹3,000 per share, as it views current cyclical weakness as a buying opportunity with strong long-term structural p...
5 Ideal 'Safer' Dividend Buys From Bloomberg's June Watch List
I highlight 15 dividend-paying stocks from Bloomberg's 50 Companies to Watch that meet my 'safer' criteria: free cash flow yields exceed dividend yields. The top ten dividend focus stocks offer an est...
Colgate-Palmolive declares $0.52 dividend
Stay updated on Colgate-Palmolive's $0.52/share dividend with a 2.23% yield. Key dates: ex-div July 18, payable Aug. 15.
Colgate Declares Regular Quarterly Dividend
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on August 15, 2025, to shareholders...
Colgate-Palmolive: The Defensive Growth Case Is Delivering
Colgate-Palmolive Company (CL) Presents at Annual Evercore ISI Consumer and Retail Conference Transcript
Price Over Earnings Overview: Colgate-Palmolive
Looking into the current session, Colgate-Palmolive Inc. (NYSE: CL) shares are trading at $91.90, after a 1.13% increase. Moreover, over the past month, the stock spiked by 4.57% , but in the past ye...
5 Best Stocks To Trade For Income
No one likes a flip-flopper, whether in politics or stocks. When a stock can't make up its mind on a direction or trend, it can drive investors to abandon their positions in search of greener pastures...
Colgate-Palmolive Company (CL) dbAccess Global Consumer Conference (Transcript)
Colgate-Palmolive Company (NYSE:CL) dbAccess Global Consumer Conference Call June 4, 2025 8:00 AM ETCompany ParticipantsNoel R.
Colgate-Palmolive: Pet Nutrition Is Hidden Gem; Initiate 'Strong Buy'
Colgate-Palmolive Webcasts Fireside Chat at the Fifth Annual Evercore ISI Consumer and Retail Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) President, Latin America, Juan Pablo Zamorano and Chief Investor Relations Officer and EVP, M&A, John Faucher will participate in a fireside chat...
Colgate stock: JP Morgan maintains overweight, sees FY26 revenue ramp-up and innovation-led growth
Colgate-Palmolive (India) shares will be in focus after JP Morgan reiterated an Overweight rating on the stock with a target price of ₹2,750 per share. The brokerage expects a back-ended revenue growt...
Colgate-Palmolive Announces Executive Leadership Appointments
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) today announced several executive leadership appointments that will take effect June 16, 2025. Shane Grant, 50, will join Colgate-Palmoli...
Best Dividend Aristocrats For June 2025
Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 20...
Should Dividend Stock Investors Buy Colgate-Palmolive Stock?
Best Dividend Stock to Buy: Colgate-Palmolive vs. Clorox
Colgate-Palmolive shares decline nearly 4% as Q4 net profit drops 6.5%, misses street estimates
Shares of Colgate-Palmolive (India) Ltd fell 3.97% to ₹2,553.70 on Thursday, following the announcement of its Q4FY25 results which showed weaker-than-expected earnings. The stock had closed at ₹2,659...
Stocks to watch on May 22: Brokerages bullish on ONGC, InterGlobe Aviation, Uno Minda; cautious on IndusInd Bank, bearish on Colgate, Swiggy
Brokerage reports released post Q4 earnings have led to a flurry of revisions and ratings across key stocks. While optimism remains around names like ONGC, IndiGo, and Uno Minda, brokerages turned cau...
Goldman Sachs maintains ‘Sell’ on Colgate-Palmolive; Q4 EBITDA margins disappoint
Goldman Sachs has maintained a ‘Sell’ rating on Colgate-Palmolive (India) Ltd, with a target price of ₹2,630, following the company’s Q4 FY25 earnings that reflected pressure on revenue and profitabil...
Stock in focus: Colgate-Palmolive Q4 profit declines 6.5% YoY to Rs 355 crore; revenue and margin slip
Shares of Colgate-Palmolive (India) Ltd will be in focus today, May 22, after the FMCG major reported a weaker-than-expected performance in its Q4 FY25 earnings announced post-market hours on Tuesday....